BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference
BiomX Inc. (NYSE American: PHGE), a clinical-stage company developing novel phage therapies targeting specific pathogenic bacteria, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The event is scheduled for September 9-11, 2024, at the Lotte New York Palace Hotel.
Key details include:
- CEO Jonathan Solomon will present a corporate overview
- Presentation Date: September 9, 2024
- Time: Available on-demand from 7:00 AM ET
- Webcast link provided for virtual attendance
- Replay available on BiomX's website for 90 days
Mr. Solomon will also be available for one-on-one meetings during the conference. Interested parties can register and request meetings through the provided link.
BiomX Inc. (NYSE American: PHGE), un'azienda in fase clinica che sviluppa terapie con fagi innovativi mirate a specifici batteri patogeni, ha annunciato la sua partecipazione alla 26ª Conferenza Globale di Investimenti Annuale H.C. Wainwright. L'evento si svolgerà dal 9 all'11 settembre 2024, presso il Lotte New York Palace Hotel.
I dettagli principali includono:
- Il CEO Jonathan Solomon presenterà una panoramica aziendale
- Data della presentazione: 9 settembre 2024
- Orario: Disponibile on-demand dalle 7:00 AM ET
- Link per il webcast fornito per la partecipazione virtuale
- Rivisitazione disponibile sul sito web di BiomX per 90 giorni
Il signor Solomon sarà disponibile anche per incontri individuali durante la conferenza. Le parti interessate possono registrarsi e richiedere incontri attraverso il link fornito.
BiomX Inc. (NYSE American: PHGE), una empresa en etapa clínica que desarrolla nuevas terapias con fagos dirigidas a bacterias patógenas específicas, ha anunciado su participación en la 26ª Conferencia Global Anual de Inversiones H.C. Wainwright. El evento está programado del 9 al 11 de septiembre de 2024, en el Lotte New York Palace Hotel.
Los detalles clave incluyen:
- El CEO Jonathan Solomon presentará una visión general de la empresa
- Fecha de la presentación: 9 de septiembre de 2024
- Hora: Disponible bajo demanda a partir de las 7:00 AM ET
- Enlace de webcast proporcionado para la asistencia virtual
- Repetición disponible en el sitio web de BiomX durante 90 días
El Sr. Solomon también estará disponible para reuniones individuales durante la conferencia. Las partes interesadas pueden registrarse y solicitar reuniones a través del enlace proporcionado.
BiomX Inc. (NYSE American: PHGE), 특정 병원균 박테리아를 타겟으로 하는 혁신적인 바이러스 요법을 개발 중인 임상 단계의 기업이 H.C. Wainwright 제26회 연례 글로벌 투자 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2024년 9월 9일부터 11일까지 뉴욕 롯데 팰리스 호텔에서 열릴 예정입니다.
주요 세부 사항은 다음과 같습니다:
- CEO Jonathan Solomon이 기업 개요를 발표합니다
- 발표 날짜: 2024년 9월 9일
- 시간: 동부 표준시 기준 오전 7시부터 주문형으로 이용 가능
- 온라인 참석을 위한 웹캐스트 링크 제공
- BiomX 웹사이트에서 90일 동안 재생 가능
Solomon 씨는 또한 회의 동안 개별 회의를 가질 수 있습니다. 관심 있는 분들은 제공된 링크를 통해 등록하고 회의 요청을 할 수 있습니다.
BiomX Inc. (NYSE American: PHGE), une entreprise en phase clinique développant des thérapies phagiques novatrices ciblant des bactéries pathogènes spécifiques, a annoncé sa participation à la 26e Conférence Annuelle Mondiale des Investisseurs H.C. Wainwright. L'événement est prévu du 9 au 11 septembre 2024, au Lotte New York Palace Hotel.
Les principaux détails incluent :
- Le PDG Jonathan Solomon présentera un aperçu de l'entreprise
- Date de la présentation : 9 septembre 2024
- Heure : Disponible à la demande à partir de 7h00 ET
- Lien de webdiffusion fourni pour la participation virtuelle
- Rediffusion disponible sur le site de BiomX pendant 90 jours
M. Solomon sera également disponible pour des réunions individuelles pendant la conférence. Les parties intéressées peuvent s'inscrire et demander des réunions via le lien fourni.
BiomX Inc. (NYSE American: PHGE), ein Unternehmen in der klinischen Phase, das neuartige Phagentherapien entwickelt, die sich gegen spezifische pathogene Bakterien richten, hat seine Teilnahme an der 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright bekannt gegeben. Die Veranstaltung findet vom 9. bis 11. September 2024 im Lotte New York Palace Hotel statt.
Wesentliche Details sind:
- CEO Jonathan Solomon wird einen Unternehmensüberblick präsentieren
- Präsentationsdatum: 9. September 2024
- Uhrzeit: Auf Abruf verfügbar ab 7:00 Uhr ET
- Webcast-Link für die virtuelle Teilnahme bereitgestellt
- Wiederholung auf der Website von BiomX für 90 Tage verfügbar
Herr Solomon wird auch für Einzelgespräche während der Konferenz zur Verfügung stehen. Interessierte Parteien können sich registrieren und Gespräche über den bereitgestellten Link anfordern.
- None.
- None.
GAITHERSBURG, Md., Sept. 04, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announces today that Jonathan Solomon, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 26th Annual Global Investment Conference. The conference is being held on September 9 - 11, 2024 at the Lotte New York Palace Hotel.
| Presentation Date: | September 9, 2024 | |
| Time: | Available on-demand starting at 7:00 AM ET | |
| Webcast Link: | https://journey.ct.events/view/d258dc7c-4d95-483c-9e0e-be6af1e9343d |
A replay of the presentation can be found on the Company’s website under Events & Presentations and will be available for 90 days: https://ir.biomx.com/news-events
Mr. Solomon will be available for one-on-one meetings throughout the conference. To request a meeting and to register for the conference, click here: https://hcwevents.com/annualconference/
About BiomX
BiomX is a clinical-stage company leading the development of natural and engineered phage cocktails and personalized phage treatments designed to target and destroy harmful bacteria for the treatment of chronic diseases with substantial unmet needs. BiomX discovers and validates proprietary bacterial targets and applies its BOLT (“BacteriOphage Lead to Treatment”) platform to customize phage compositions against these targets. For more information, please visit www.biomx.com, the content of which does not form a part of this press release.
Contacts:
BiomX, Inc.
Assaf Oron
+97254-2228901
assafo@biomx.com
INVESTORS:
CORE IR
Peter Seltzberg
peters@coreir.com
FAQ
When is BiomX (PHGE) presenting at the H.C. Wainwright Global Investment Conference?
Where can I watch the BiomX (PHGE) presentation from the H.C. Wainwright conference?
What is the focus of BiomX's (PHGE) research and development?
How can investors arrange meetings with BiomX (PHGE) management at the H.C. Wainwright conference?
